KnE Life Sciences

ISSN: 2413-0877

The latest conference proceedings on life sciences, medicine and pharmacology.

Depressive Symptoms in High-Risk Pregnancies During the COVID-19 Pandemic

Published date: Feb 07 2022

Journal Title: KnE Life Sciences

Issue title: 5th International Conference in Nursing (IVCN)

Pages: 440–446

DOI: 10.18502/kls.v7i2.10339

Authors:

Rizal IlbertSTIKep PPNI Jawa Barat, Bandung, West Java, Indonesia

Dewi Marfuahdewi.marfuah@yahoo.comMaternity Department, STIKep PPNI Jawa Barat, Bandung, West Java, Indonesia

Abstract:

A high-risk pregnancy is one that has a higher risk than a normal pregnancy, both to the mother and to her baby, which can cause disability, disease or even death before or after delivery. In the city of Bandung, there were 29 cases of maternal mortality in 2019. One of the potential effects of a risky pregnancy is antenatal depression. The results of previous research conducted in Indonesia showed that 50% of pregnant women are at risk of experiencing depressive symptoms. The COVID-19 pandemic can trigger stress, and unresolved stress can cause depression and endanger the mental and physical health of pregnant women and their babies. This study aimed to describe the symptoms of depression in mothers with high-risk pregnancies. A descriptive quantitative approach was used with a cross-sectional design and there were 60 participants. The inclusion criteria were at-risk pregnant women who had been screened using the Poedji Rochjati Score Card, had a smartphone, and were able to communicate well. The instrument used was the Patient Health Questionnaire-9. The findings showed that 90% of women with high-risk pregnancies during the pandemic experienced symptoms of depression and 10% experienced mild depression. The majority of the depressive symptoms that were experienced were somatic-gastrointestinal symptoms. It can be concluded that symptoms of depression in pregnant women increased during the COVID-19 pandemic. So, it is necessary to improve the quality of pregnancy services to overcome the symptoms of depression in pregnant women.

Keywords: depressive symptoms, high-risk pregnancy, COVID-19 pandemic

References:

[1] Widiastuti I, Marfuah D. The screening description of mothers with risk pregnancy. KnE Life Sciences. 2019:422–428.

[2] Ariska S, Marfuah D. The description of problems correlated to pregnancy. KnE Life Sciences. 2015;2019:463–475.

[3] Sut HK. Anxiety, depression, and related factors in pregnant women during the COVID-19 pandemic in Turkey: A web - based cross - sectional study. Perspectives in Psychiatric Care. 2020.

[4] Kusuma PD, Marchira CR, Prawitasari S. Patient health questionnaire-9 (Phq-9) efektif untuk mendeteksi risiko depresi postpartum. 2018;5(Sept):428–433.

[5] Sari RA, Kedokteran F, Lampung U. Literature review: Depresi postpartum. Jurnal Kesehatan. 2020;11:167–174.

[6] Marfuah D, Mutiar A. Indonesia counseling: Screening of risky pregnancy to creating healthy pregnant women in Bandung. Jurnal Abdi Masyarakat. 2020;1(1):1–6.

[7] Graham AL. Potential maternal and infant outcomes from coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections. 2020:1–16.

[8] Literatur S. The baby blues and postnatal depression. 2008;Sept:191–193.

[9] Wang C, Wu C, Wang C, Long C. Impact of COVID-19 on pregnancy. International Journal of Medical Sciences. 2021;18.

Download
HTML
Cite
Share
statistics

223 Abstract Views

204 PDF Downloads